32.2% OF INACTIVE HBSAG CARRIERS ACHIEVED CLINICAL CURE AT 48 WEEKS WITH PEGYLATED INTERFERON ALPHA-2B THERAPY: A MULTICENTER REAL- WORLD STUDY ( STARHB PROJECT IN CHINA)-2-YEAR DATA UPDATE

被引：0

作者：

Zhao, Jing ^{[1
]}

Ren, Shan ^{[1
]}

Zheng, Sujun ^{[1
]}

Lin, Bingliang ^{[2
]}

Jiang, Yongfang ^{[3
]}

Ruan, Qingfa ^{[4
]}

Huang, Yan ^{[5
]}

Zeng, Yilan ^{[6
]}

Geng, Jiawei ^{[7
]}

Cao, Haifang ^{[8
]}

Zhang, Wenhua ^{[9
]}

Guo, Ying ^{[10
]}

Mao, Xiaorong ^{[11
]}

Gao, Zhiliang ^{[2
]}

Shi, Tianyuan ^{[12
]}

Zhu, Yueyong ^{[13
]}

Yu, Zujiang ^{[14
]}

Wu, Xiaoping ^{[15
]}

Mao, Qing ^{[16
]}

Xue, Xiulan ^{[17
]}

He, Yingli ^{[18
]}

Shang, Jia ^{[19
]}

Dang, Shuangsuo ^{[20
]}

Zhao, Haidong ^{[21
]}

Fan, Rongshan ^{[22
]}

Yang, Jiangling ^{[23
]}

Lian, Jianqi ^{[24
]}

Gao, Haibing ^{[25
]}

Chen, Xinyue ^{[1
]}

机构：

[1] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China

[2] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Peoples R China

[3] Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China

[4] Xiamen Hosp Tradit Chinese Med, Xiamen, Peoples R China

[5] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China

[6] Publ Hlth Clin Ctr Chengdu, Chengdu, Peoples R China

[7] First Peoples Hosp Yunnan Prov, Kunming, Yunnan, Peoples R China

[8] 4th Peoples Hosp Qinghai Prov, Xining, Peoples R China

[9] Gansu Wuwei Tumour Hosp, Wuwei, Peoples R China

[10] Third Peoples Hosp Taiyuan, Taiyuan, Peoples R China

[11] Lanzhou Univ, Hosp 1, Lanhzou, Peoples R China

[12] Second Hosp Longyan, Longyan, Peoples R China

[13] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China

[14] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

[15] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China

[16] AMU, Southwest Hosp, Chongqing, Peoples R China

[17] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China

[18] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China

[19] Peoples Hosp Henan Prov, Zhengzhou, Peoples R China

[20] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China

[21] Xiamen Changgeng Hosp Co Ltd, Xiamen, Peoples R China

[22] Shenzhen Hosp Integrated Tradit Chinese & Western, Shenzhen, Peoples R China

[23] Ningbo Beilun Dist Tradit Chinese Med Hosp, Ningbo, Peoples R China

[24] Air Force Med Univ, Affiliated Hosp 2, Xian, Peoples R China

[25] Fujian Med Univ, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China

来源：

HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

399

引用

页码：S287 / S288

页数：2

共 7 条

[1] Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update
Xie, Chan
Xie, Dongying
Fu, Lei
Zhang, Wen-hua
Wei, Jia
Li, Guojun
Yang, Jiahong
Chen, Xinyue
Li, Jia-bin
Shang, Jia
Guan, Yu-juan
Jiang, Yongfang
Guo, Ying
Zeng, Yi-lan
Chang, Jiabao
Peng, Yanzhong
Lin, Minghua
Huang, Guangyu
Li, Jia
Gu, Shengwang
Geng, Jia-wei
Gao, Zhiliang
JOURNAL OF HEPATOLOGY, 2022, 77 : S838 - S838
[2] FUNCTIONAL CURE BASED ON PEGYLATED INTERFERON α-2b THERAPY IN NUCLEOSIDE ANALOG-SUPPRESSED HBEAG NEGATIVE CHRONIC HEPATITIS B: A MULTICENTER REAL-WORLD STUDY (EVEREST PROJECT IN CHINA)-4 YEARS DATA UPDATE
Mo, Zhishuo
Xie, Dongying
Fu, Lei
Zhang, Wenhua
Wei, Jia
Li, Guojun
Yang, Jiahong
Chen, Xinyue
Li, Jiabin
Shang, Jia
Guan, Yujuan
Jiang, Yongfang
Guo, Ying
Zeng, Yilan
Chang, Jiabao
Peng, Yanzhong
Lin, Minghua
Huang, Guangyu
Li, Jia
Gu, Shengwang
Geng, Jiawei
Gao, Zhiliang
HEPATOLOGY, 2022, 76 : S24 - S25
[3] Functional cure and prediction analysis of pegylated interferon alpha-2b in HBeAg negative chronic hepatitis B patients with normal ALT (Ice-breaking Project in China): an interim analysis update
Zhang, Chong
Zeng, Dawu
Cai, Dachuan
Xue, Xiulan
Zhang, Lingyi
Song, Baojun
Gao, Yufeng
Huang, Yan
Shang, Jia
Wu, Xiaofeng
Zhang, Ying
Jin, Hua
Chen, Hui
Tang, Hong
Lu, Xiaobo
Guan, Yujuan
Min, Feng
Xu, Liang
Li, Gang
Wang, Zhenguang
Dou, Xiaoguang
JOURNAL OF HEPATOLOGY, 2024, 80 : S803 - S803
[4] Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis
Zhang, Chong
Zeng, Da-Wu
Cai, Da-Chuan
Xue, Xiu-Lan
Zhang, Ling-Yi
Song, Bao-Jun
Gao, Yu-Feng
Huang, Yan
Shang, Jia
Wu, Xiao-Feng
Zhang, Ying
Jin, Hua
Chen, Hui
Tang, Hong
Lu, Xiaobo
Guan, Yujuan
Min, Feng
Xu, Liang
Li, Gang
Wang, Zhen-Guang
Dou, Xiaoguang
JOURNAL OF HEPATOLOGY, 2023, 78 : S1165 - S1166
[5] FUNCTIONAL CURE BASED ON PEGYLATED INTERFERON α IN LONG-TERM NUCLEOSIDE ANALOG SUPPRESSED HBEAG NEGATIVE CHRONIC HEPATITIS B: A MULTICENTER REAL-WORLD STUDY (EVEREST PROJECT IN CHINA), A SEQUENTIAL REPORT - THE PREDICTORS FOR HBsAg LOSS
Wu, Zeqian
Xie, Dongying
Fu, Lei
Zhang, Wenhua
Wei, Jia
Shang, Jia
Li, Guojun
Guo, Ying
Yang, Jiahong
Guan, Yujuan
Li, Jiabin
Chang, Jiabao
Huang, Guangyu
Peng, Yanzhong
Lin, Minghua
Zeng, Yilan
Li, Jia
Jiang, Jiaji
Jiang, Yongfang
Gu, Ye
Geng, Jiawei
Gao, Zhiliang
HEPATOLOGY, 2021, 74 : 483A - 483A
[6] Functional cure based on pegylated interferon α in long-term nucleoside analog suppressed HBeAg negative chronic hepatitis B: A multicenter real-world study (everest project in china), a sequential report the predictors for HBsAg loss
Wu, Ze-Qian
Xie, Dong-Ying
Fu, Lei
Zhang, Wenhua
Wei, Jia
Shang, Jia
Li, Guojun
Guo, Ying
Yang, Jiahong
Guan, Yujuan
Li, Jiabin
Chang, Jiabao
Huang, Guangyu
Peng, Yanzhong
Lin, MInghua
Zeng Yilan
Li, Jia
Jiang, Jiaji
Jiang, Yongfang
Gu, Ye
Geng, Jiawei
Gao, Zhi-liang
JOURNAL OF HEPATOLOGY, 2021, 75 : S759 - S759
[7] Effects of interferon-based therapies in functional cure and hepatocellular carcinoma risk reduction in patients with chronic hepatitis B: real-world evidence from 2-year data of OASIS project
Zhang, Qiran
Sun, Feng
Yu, Yiqi
Zhao, Tingting
Sui, Shulan
Zhang, Jiming
Shang, Jia
Geng, Jiawei
He, Yignli
Guo, Ying
Zhao, Caiyan
Zhu, Yueyong
Yan, Xuebing
Zhang, Wenhong
JOURNAL OF HEPATOLOGY, 2023, 78 : S1133 - S1134

← 1 →